Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Juliet Bakker Tammenoms


  • at Axonics Modulation Technologies Inc. (AXNX), 2019-07-01
  • Large Shareholder at Molecular Templates Inc. (MTEM), 2018-09-25
  • at Tricida Inc. (TCDA), 2018-07-03
  • Large Shareholder at Aptinyx Inc. (APTX), 2018-06-26
  • Large Shareholder at Aimmune Therapeutics Inc. (AIMT), 2018-02-26
  • Large Shareholder at Collegium Pharmaceutical Inc (COLL), 2017-12-12
  • Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2017-07-27
  • Large Shareholder at Corcept Therapeutics Inc (CORT), 2016-12-19
  • Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2014-11-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AXNX $15.00 533,333 Large Shareholder, Director 2,933,333 2018-11-02 Filing
AIMT $32.00 9,375 Large Shareholder 16,651 2018-02-22 Filing